Intravenous (IV) vs Intra-articular Stem Cell Therapy for Knee Arthritis
In recent times, there has been a surge in regenerative medicine clinics advertising the transformative effects of intravenous or IV stem cell therapy, claiming it can drastically improve one’s life and alleviate pain. But how much of this is backed by clinical evidence? Clinical Evidence Behind IV Stem Cell Therapy The primary question is whether […]
Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy
IRVINE, Calif., Aug. 9, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, today announced that the U.S. Food and Drug Administration has approved it’s Investigational New Drug application for a Phase 1/2a clinical trial investigating IMM01-STEM in participants with muscle atrophy: www.clinicaltrials.gov/ct2/show/NCT05211986 The open label […]